Concepedia

Joseph Agnes

JA

Statistics

Publications

10

Citations

629

H-Index

10

Active since

2005

Affiliations

Inovio Pharmaceuticals (United States)(Current)

Hospital of the University of Pennsylvania

The Wistar Institute

Washington State University

Alliance for Multispecialty Research (United States)

Joseph Agnes is an author at Inovio Pharmaceuticals (United States) specializing in infectious diseases, vaccinology, and veterinary medicine.

Publications per year

2005–2022

10

Publications

10

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 282 citations · Full text

, , +17

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes et al. · The Journal of Infectious Diseases · 2022 · 61 citations · Full text

, , +17

Differential Expression and Sequence Conservation of the<i>Anaplasma marginale msp2</i>Gene Superfamily Outer Membrane Proteins

Susan M. Noh, Kelly A. Brayton, Donald P. Knowles et al. · Infection and Immunity · 2006 · 56 citations · Full text

, , +13

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · npj Vaccines · 2021 · 50 citations · Full text

, , +17

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen, Pablo Tebas, Joseph Agnes et al. · medRxiv · 2021 · 43 citations · Full text

, , +17

1–5 of 10